Our Team
Board of Directors
The Atelerix Life Sciences Team is experienced in small molecule bio-technology, and has the drive to bring new drugs to market.
Nick Plumeridge
CEO and Chairman
- Over 30 years of global pharmaceutical experience, Global MNC, Aventis, Serono, Takeda through to emerging Biotech Epirus, Mabxience
- Executive roles in corporate development, strategic planning, BD&L and commercial operations
- Expertise spans the entire product lifecycle from early product development through to commercial launch
- Significant fundraising experience, working with private equity and venture capital from start up to IPO
- International experience, US, Asia Pacific, Japan, Latam and Europe
Peter Barton Hutt, LL.B
Director & Senior Thought Leader
- Senior Counsel, Covington & Burling LLP, specializing in Food and Drug Law
- Former General Counsel to the FDA
- Served on Board for 30+ biotech companies
- Harvard Law food & drug law teacher since 1994
- Member, National Academy of Medicine since 1971
William Akridge
Director and Series Seed Co-Lead
- Founder, Akridge Ventures
Scientific Co-Founders
Benjamin Gaston, MD
Benjamin Gaston, MD
Member, Scientific Advisory Board
Co-Inventor of the novel platform technology
NIH and foundation funded for platform technology development
Professor of Pediatrics and Vice Chair for Translational Research, Herman B Wells Center, Indiana University School of Medicine
James Bates, MD/PhD
Chief Medical Officer (Full Time)
Co-Inventor of the novel platform technology
Former practicing anesthesiologist, University of Iowa
Ph.D., Biochemistry/Molecular Biology, University of California-Santa Barbara
MD, Medicine, University of Miami School of Medicine
Stephen Lewis, PhD
Member, Scientific Advisory Board
Co-Inventor of the novel platform technology
NIH and foundation funded for platform technology development
Professor, Department of Pediatrics, Division of Pulmonology, Allergy and Immunology, Case Western Reserve University School of Medicine